Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Heart Failure
100%
Macrophages
36%
Tumor Necrosis Factor-α
35%
Left Ventricular Function
33%
Myocardial Infarction
29%
Myocytes
28%
Cardiomyocytes
27%
Molecular Imaging
26%
Heart Failure with Preserved Ejection Fraction (HFpEF)
25%
Myocardium
24%
Patients with Heart Failure
23%
Nanoparticles
21%
Perfluorocarbon Nanoparticles
20%
Inflammation
19%
Acute Decompensated Heart Failure
19%
Cardiovascular Disease
18%
Cardiac Function
17%
Diastolic Function
17%
Left Ventricular Remodeling
17%
Overexpression
16%
Cardiac Hypertrophy
16%
K+ Current
15%
Transgenic Mice
13%
Cardiac Remodeling
13%
Mouse Model
13%
E Wave
13%
Acute Myocardial Infarction
13%
Obesity
13%
Gene Expression
12%
Autophagy
12%
Peroxisome Proliferator-activated Receptor
11%
Failing Heart
11%
Coronary Artery Disease
11%
Ca2+
11%
95% Confidence Interval
11%
Left Ventricular Ejection Fraction
11%
Human Heart
11%
Heart Failure Patients
11%
Echocardiographic
11%
CCR2
10%
Dilated Cardiomyopathy
10%
Angiogenesis
10%
Targeted Nanoparticles
10%
Interleukin-1β
10%
Hypertrophy
10%
Mycobacterium Tuberculosis (M. tb)
10%
COVID-19
10%
Cardiac Magnetic Resonance Imaging (cMRI)
10%
Diabetes
10%
Kv4.2
10%
Apoptosis
9%
Insulin Resistance
9%
Cardioprotection
9%
Contrast Agent
9%
Left Ventricular Assist Device
9%
Integrin
9%
Mouse Heart
9%
Cardiomyopathy
9%
Hazard Ratio
9%
Clinical Trials
9%
Inflammatory Cytokines
9%
Left Ventricular Dysfunction
9%
Congestive Heart Failure
8%
Atrial Fibrillation
8%
Left Ventricle
8%
Arrhythmia
8%
Coronary Heart Disease
8%
Ischemia-reperfusion Injury
8%
Hypertrophic Cardiomyopathy
8%
Diastolic Filling
8%
Pressure Overload
8%
Molecular Targets
8%
Disease Progression
8%
Type 2 Diabetes Mellitus (T2DM)
8%
Left Ventricular End-diastolic Pressure (LVEDP)
7%
Clinical Outcomes
7%
Positron Emission Tomography/computed Tomography (PET/CT)
7%
Cardiac-specific
7%
Heart Failure Therapy
7%
Toll-like
7%
Caveolin-1 (Cav-1)
7%
Transcription Factor
7%
Fibrin
7%
Ejection Fraction
7%
Adrenergic Receptors
7%
Murine Model
7%
Lipids
7%
Recent Advances
7%
Cardiac Dysfunction
7%
Dominant Negative
7%
Inflammatory Mediators
7%
Echocardiography
7%
Tumor Necrosis Factor Receptor 1 (TNFR1)
7%
Genotype
7%
Fibrosis
7%
Transmitral Flow
7%
Transcription Factor EB
7%
Chronic Heart Failure
7%
Lung
7%
Induced Pluripotent Stem Cells (iPSCs)
7%
Medicine and Dentistry
Congestive Heart Failure
91%
Diseases
24%
Molecular Imaging
23%
Cardiac Muscle Cell
21%
Nanoparticle
21%
Diastolic Function
20%
Cardiovascular System
20%
Myocardial Infarction
19%
Heart Function
17%
Heart Ventricle Remodeling
15%
Macrophage
15%
Cardiovascular Disease
14%
Left Ventricular Assist Device
14%
Ejection Fraction
13%
Echocardiography
13%
Inflammation
12%
Myocardium
12%
Heart Left Ventricle Ejection Fraction
11%
Magnetic Resonance Imaging
11%
Hemodynamic
11%
Ventricular Hypertrophy
10%
Diabetes
10%
Genetics
10%
Left Ventricle
10%
Contrast Medium
10%
COVID-19
10%
Heart Failure with Preserved Ejection Fraction
10%
Cardiac Dysrhythmia
10%
Myocardial Disease
10%
Tumor Necrosis Factor
10%
Biological Marker
10%
Atherosclerosis
9%
Heart Muscle Ischemia
9%
Ischemic Heart Disease
9%
Heart Graft
9%
Assisted Circulation
9%
Infarction
9%
Ventricular Assist Device
9%
Diastole
8%
Coronary Artery Disease
8%
Lung
8%
Placebo
8%
Clinical Trial
8%
Angiogenesis
7%
Dilated Cardiomyopathy
7%
Fluorocarbon
7%
Heart Failure with Reduced Ejection Fraction
7%
Transgenic Mouse
7%
Cytokine
7%
Diabetes Mellitus
7%
Heart Transplantation
7%
Gene Expression
7%
Hazard Ratio
7%
Quality of Life
7%
Exercise
6%
Integrin
6%
Hypertrophic Cardiomyopathy
6%
Heart Left Ventricle Failure
6%
Heart Disease
6%
Positron Emission Tomography
6%
Diastolic Dysfunction
6%
Endothelial Cell
6%
Insulin Resistance
6%
Physiology
5%
Monocyte
5%
Fatty Acid
5%
Systolic Function
5%
Calcium Ion
5%
Ischemia
5%
Acute Heart Infarction
5%
Heart Left Ventricle Pressure
5%
Heart Left Ventricle Function
5%
Pathogenesis
5%
Cardiac Magnetic Resonance Imaging
5%
Cardiology
5%
In Vitro
5%
Hypertension
5%
Potassium Current
5%
Systolic Heart Failure
5%
Radiation Therapy
5%
Cardiac Catheterization
5%
Cardiac Fibrosis
5%
Signal Transduction
5%
Oxygen Consumption
5%
Heart Muscle Metabolism
5%
Fatty Acid Metabolism
5%
Fibrosis
5%
Glucose
5%
Heart Ventricle Function
5%
Biochemistry, Genetics and Molecular Biology
Cardiac Muscle Cell
55%
Macrophage
22%
Gene Expression
17%
Tumor Necrosis Factor
17%
Autophagy
17%
Deficiency
15%
Genetics
14%
Transcription Factors
13%
Lipid
13%
Peroxisome Proliferator-Activated Receptor
13%
Heart Function
12%
Coronary Artery Disease
12%
Reperfusion
12%
Knockout Mouse
11%
Mouse Model
11%
Heart Ejection Fraction
11%
Metabolic Pathway
11%
Wild Type
11%
Potassium Current
11%
Rat
10%
Mitochondrion
10%
Fibroblast
10%
Messenger RNA
10%
Transgenic Mouse
9%
Programmed Cell Death
9%
Cholesterol
9%
Signal Transduction
9%
Homeostasis
9%
Lysosome
9%
Caveolin 1
9%
Allele
9%
Cell Death
9%
phosphorylation
9%
Genomics
8%
Hemodynamic
8%
Kinase
8%
Phosphotransferase
8%
Proteomics
8%
Ion Channel
8%
Blood Plasma
8%
Promoter Region
7%
Glucose
7%
Genotyping
7%
Electric Potential
7%
N-Terminus
6%
Adipocyte
6%
Genetic Divergence
6%
Oxidative Stress
6%
Potassium Channel
6%
Maturity Onset Diabetes of the Young
6%
Enzyme
6%
Lipid Metabolism
6%
Upregulation
6%
Cardiac Dysrhythmia
6%
Skeletal Muscle
6%
Beta Oxidation
5%
Genome-Wide Association Study
5%
Single-Nucleotide Polymorphism
5%
Triglyceride
5%
Tumor Necrosis Factor Receptor
5%
Exome Sequencing
5%
Human Induced Pluripotent Stem Cell
5%
Protein Kinase B
5%
Action Potential
5%
Heart Ventricle Function
5%
Insulin Resistance
5%
Elastin
5%
Molecular Mechanism
5%
Atrial Fibrillation
5%
Cytokine
5%
Insulin
5%
Adenosine Triphosphate
5%
Integrin
5%
Heart Muscle Metabolism
5%